Testing effectiveness (Phase 2)UnknownNCT03336073What this trial is testingCarfilzomib, Cyclophosphamide, Dexamethasone in Multiple MyelomaWho this might be right forMultiple Myeloma PETHEMA Foundation 199
Testing effectiveness (Phase 2)Temporarily pausedNCT06876142What this trial is testingCombination Therapy (Mirdametinib and Sirolimus) for RAS Mutated Relapsed Refractory Multiple MyelomaWho this might be right forMultiple MyelomaRelapsed and/or Refractory Multiple Myeloma (RRMM) National Cancer Institute (NCI) 54
Testing effectiveness (Phase 2)Ended earlyNCT01670994What this trial is testingQUILT-3.020: A Study of ALT-801 in Patients With Relapsed or Refractory Multiple MyelomaWho this might be right forRelapsed or Refractory Multiple Myeloma Altor BioScience 6
Large-scale testing (Phase 3)Study completedNCT00799461What this trial is testingInternet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors of Hematopoietic Stem Cell Transplant Cope With Late ComplicationsWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+89 more Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium 1,337
Large-scale testing (Phase 3)Study completedNCT01324947What this trial is testingStudy to Evaluate the Safety and Efficacy of Pomalidomide Monotherapy in Subjects With Refractory or Relapsed Refractory Multiple MyelomaWho this might be right forMultiple Myeloma Celgene 74
Large-scale testing (Phase 3)Study completedNCT02990338What this trial is testingMultinational Clinical Study Comparing Isatuximab, Pomalidomide, and Dexamethasone to Pomalidomide and Dexamethasone in Refractory or Relapsed and Refractory Multiple Myeloma PatientsWho this might be right forPlasma Cell Myeloma Sanofi 307
Testing effectiveness (Phase 2)Study completedNCT00253578What this trial is testingSorafenib in Treating Patients With Relapsed or Refractory Multiple MyelomaWho this might be right forRefractory Multiple Myeloma National Cancer Institute (NCI) 40
Early research (Phase 1)Ended earlyNCT03379584What this trial is testingA Safety Study of SGN-CD48A in Patients With Multiple MyelomaWho this might be right forMultiple Myeloma Seagen Inc. 14
Early research (Phase 1)Ended earlyNCT03445663What this trial is testingStudy Evaluating AMG 424 in Subjects With Multiple MyelomaWho this might be right forRelapsed/ Refractory Multiple Myeloma Xencor, Inc. 27
Not applicableStudy completedNCT05887206What this trial is testingCorneal Toxicity in Patients Treated by Belantamab MafodotinWho this might be right forMyeloma Multiple Centre Hospitalier Universitaire de Saint Etienne 43
Not applicableEnded earlyNCT00008216What this trial is testingBlood Stem Cell Transplant in Treating Patients With Hematologic CancerWho this might be right forAdult Langerhans Cell HistiocytosisChildhood Langerhans Cell HistiocytosisLeukemia+4 more Columbia University 48
Testing effectiveness (Phase 2)Study completedNCT01775553What this trial is testingStudy of High Dose Carfilzomib in Multiple Myeloma Patients Who Have Progressed On Standard Dose CarfilzomibWho this might be right forRelapse Multiple MyelomaRefractory Multiple Myeloma Ajai Chari 13
Testing effectiveness (Phase 2)Ended earlyNCT03910439What this trial is testingAvelumab in Combination With Hypofractionated Radiotherapy in Patients With Relapsed Refractory Multiple MyelomaWho this might be right forMyeloma, MultipleMyeloma-Multiple National Cancer Institute (NCI) 4
Early research (Phase 1)Active Not RecruitingNCT06381141What this trial is testingCLN-619 (Anti-MICA/MICB Antibody) in Patients With Relapsed and Refractory Multiple MyelomaWho this might be right forMultiple Myeloma Cullinan Therapeutics Inc. 30
Testing effectiveness (Phase 2)Ended earlyNCT01101594What this trial is testingHLL1-DOX (Milatuzumab-Doxorubicin Antibody-Drug Conjugate) in Patients With Multiple MyelomaWho this might be right forMultiple Myeloma Gilead Sciences 17
Testing effectiveness (Phase 2)UnknownNCT02248402What this trial is testingAutologous Dendritic Cell Therapy in Patients With Relapsed or Refractory Multiple MyelomaWho this might be right forMultiple Myeloma Chonnam National University Hospital 15
Early research (Phase 1)UnknownNCT05412329What this trial is testingStudy of Dual Targeted CD19/BCMA FASTCART GC012F in Relapsed/ Refractory Multiple MyelomaWho this might be right forMultiple Myeloma Shanghai Changzheng Hospital 9
Early research (Phase 1)Active Not RecruitingNCT05666700What this trial is testingCAR-T Cell Therapy in RelApsed/Refractory Myeloma With ExtrameduLlary Disease - an in Vivo Imaging and Molecular Monitoring StudyWho this might be right forExtramedullary Myeloma Peter MacCallum Cancer Centre, Australia 10
Very early researchUnknownNCT04626752What this trial is testingCAR-T Cells in Treating Patients With Relapsed or Refractory Multiple MyelomaWho this might be right forRelapsed or Refractory Multiple Myeloma Hebei Senlang Biotechnology Inc., Ltd. 50
Testing effectiveness (Phase 2)UnknownNCT05509530What this trial is testingSafety and Efficacy of Anti-BCMA/GPRC5D CAR-T Cell Therapy in Treating Relapsed and Refractory Multiple Myeloma(rr/MM)Who this might be right forMultiple Myeloma Xuzhou Medical University 30